Search details
1.
Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors.
Nat Cancer
; 4(4): 485-501, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36997747
Results
1 -
1
de 1
1
Next >
>>